DPLO News and Press, Diplomat Pharmacy Inc. From 08/08/19

Diplomat Pharmacy (NYSE: DPLO ) is scheduled to announce Q2 earnings results on Friday, August 9th, before market open. The consensus EPS Estimate is $0.07 (-58.8% Y/Y) and the consensus Revenue Estimate is $1.23B (-13.4% Y/Y). Over the last 2 years, DPLO  has beaten EPS estimates...

FLINT, Mich. , Aug. 8, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), is pleased to announce an exclusive agreement between Diplomat and Allergy Partners, P.A., to manage in-office and in-home delivery and administration of infusion drugs and biologics. The agreement...

FLINT, Mich. , July 18, 2019 /PRNewswire/ --  Diplomat Pharmacy, Inc. (NYSE: DPLO),  will release its second-quarter 2019 operating results before market open Friday, August 9 . A conference call and live webcast will be held at 8:30 a.m. ET . Shareholders and interes...

Immunic (NASDAQ: IMUX ) +17% . More news on: Immunic, Inc., Foresight Autonomous Holdings Ltd., Jaguar Health, Inc., Stocks on the move, Read more ...

FLINT, Mich. , July 9, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), announced the launch of EMPOWER ECOSYSTEM , an online collection of services and tools to help patients and caregivers manage the physical, social, and emotional impact of their, or their loved ones, c...

The iShares U.S. Healthcare Providers ETF (NYSE: IHF ) tracks a basket of stocks with exposure to health insurance, diagnostics, specialized treatment, and healthcare industry service providers. The exchange-traded fund with an inception date in 2006 currently has over $850 million in assets...

Diplomat Pharmacy, Inc. (DPLO) Q1 2019 Earnings Conference Call May 07, 2019 8:30 AM ET Company Participants Terri Anne Powers - Vice President, Investor Relations Brian Griffin - Chairman & Chief Executive Officer Dan Davison - Chief Financial Officer Conference Call Part...

The following slide deck was published by Diplomat Pharmacy, Inc. in conjunction with their 2019 Q1 earnings Read more ...

Diplomat Pharmacy (NYSE: DPLO ): Q1 GAAP EPS of -$0.19 misses by $0.26 . More news on: Diplomat Pharmacy, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

FLINT, Mich. , May 7, 2019 /PRNewswire/ --  Diplomat Pharmacy, Inc. (NYSE: DPLO),  the nation's largest independent provider of specialty pharmacy and infusion services, announced financial results for the quarter ended March 31, 2019 .  All comparisons, unless otherwis...